Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats-Reference-Cited by-同舟云学术

Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats

Published:2022-12 Issue: Volume:191 Page:69-77
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Dixit Madhura P.,Sammeta Shivkumar S.,Dhokne Mrunali D.,Mangrulkar Shubhada,Upadhya Manoj A.,Umekar Milind J.,Taksande Brijesh G.,Kotagale Nandkishor R.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference60 articles.

1. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents;Albaugh;Obesity,2006

2. Pharmacokinetics and tissue distribution of olanzapine in rats;Aravagiri;Biopharmaceut. Drug Dispos.,1999

3. The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis;Arndt;Am. J. Physiol. Cell Physiol.,2009

4. Selective inhibition of inducible nitric oxide synthase by agmatine;Auguet;Jpn. J. Pharm.,1995

5. Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate;Bergin;Sci. Rep.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding mitochondrial quality control mechanisms: Identifying treatment targets for enhanced cellular health;Mitochondrion;2024-09

2. The prenatal use of agmatine prevents social behavior deficits in VPA‐exposed mice by activating the ERK/CREB/BDNF signaling pathway;Birth Defects Research;2024-04

3. Systematic analysis of the results of fundamental and clinical studies of ethifoxin;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023